Therefore, our findings further support the notion that coinciding loss of P53 activity and EGFR activation may signal the transition to invasive tumour growth, and that EGFR mutation may actually better define specific subtypes of early lesions less likely to progress to overt invasive carcinoma. Here, TP53 is linked to neoplasm.